Title
Evaluation of two brands of test of elisa for the diagnosis of htlv-1 against peruvian samples
Other title
Evaluación de dos marcas comerciales de pruebas de elisa para el diagnóstico de htlv-1 frente a muestras peruanas
Date Issued
01 December 2020
Access level
open access
Resource Type
journal article
Author(s)
Tasayco-Magallanes E.
Cárdenas-Bustamante F.
Briceño-Espinoza R.
Yana-Calatayud B.
Publisher(s)
Sociedad Chilena de Infectologia
Abstract
As Peru is endemic to HTLV-1, it is important to know the reliability of the most used screening trademarks in our country. In the present study, we evaluated two brands of ELISA (Biokit and Wantai) for the detection of antibodies against HTLV-1/2 against Peruvian samples. Both brands were evaluated against 242 sera: 123 positive for HTLV-1 and 119 negative for HTLV-1 (Reference: Immunoblot). We estimated diagnostic accuracy parameters. The sensitivity, specificity, PPV, NPV and validity index of Biokit were: 100%, 93.2%, 93.8%, 100%, 96.6%; respectively and Wantai were 99.1% for all parameters. We conclude that the Biokit brand is the most suitable for use in the National Reference Laboratory of Sexually Transmitted Viruses HIV/AIDS, Peru.
Start page
780
End page
783
Volume
37
Issue
6
Language
Spanish
OCDE Knowledge area
Salud pública, Salud ambiental
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-85104345148
PubMed ID
Source
Revista Chilena de Infectologia
ISSN of the container
07161018
Sources of information:
Directorio de Producción Científica
Scopus